{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-042369","form_type":"8-K","ticker":"ONCO","cik":"0001782107","company_name":"Onconetix, Inc.","filed_at":"2024-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.068788+00:00","generated_at":"2026-06-02T02:34:11.493709+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Onconetix receives Nasdaq deficiency notice for insufficient stockholders' equity; faces potential delisting","bullets":["Stockholders' equity was $1,404,476 for FY2023, below Nasdaq's $2.5M minimum requirement.","Company must submit a compliance plan to Nasdaq by June 24, 2024.","If plan accepted, Nasdaq may grant extension until November 4, 2024 to regain compliance.","Failure to regain compliance could result in delisting of ONCO common stock.","No immediate effect on listing; company can appeal any rejection decision."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-042369","json":"https://secwatch.observer/filing/0001213900-24-042369.json","markdown":"https://secwatch.observer/filing/0001213900-24-042369.md","text":"https://secwatch.observer/filing/0001213900-24-042369.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1782107/000121390024042369/0001213900-24-042369-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1782107/000121390024042369/ea0205933-8k_oncone.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T02:34:11.493709+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c61eeb54f0887518630dd3a4e67c2b90721a2adc","claim":"Onconetix, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"equity for the fiscal year ended December 31, 2023 as reported in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 1, 2024 was $1,404,476, and as of the date of the Notice, the Company did not meet the alternatives to the Minimum Stockholders’ Equity Requirement of having either (i) a market value of listed","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390024042369/0001213900-24-042369-index.htm","confidence":0.95,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5550(b)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}